Cinven has reached an agreement to acquire a stake in Vitamin Well Group from Bridgepoint Group Plc, positioning itself as the largest shareholder of the Swedish healthy beverage company. Following the transaction, which is anticipated to finalize in the latter half of this year, Bridgepoint will maintain a significant minority stake in Vitamin Well.

The stake sale values Vitamin Well at approximately €3 billion ($3.3 billion), including debt, as reported by sources familiar with the deal. Bridgepoint originally invested in Vitamin Well in 2016, when the company was valued at a lower amount.

Details regarding the financial specifics of the transaction have not been disclosed.